comunicati
VWR Appoints Dr. Nils Clausnitzer as Senior Vice President and President of EMEA-APAC Lab Business
- RADNOR, Pennsylvania, Jan. 7, 2016 /PRNewswire/ -- VWR (NASDAQ: VWR), a leading, global, independent provider of laboratory products, services and solutions, has appointed Dr. Nils Clausnitzer as its Senior Vice President and President of EMEA-APAC Lab Business. "We are delighted to have Nils join our team," said Manuel Brocke-Benz, President and CEO of VWR. "He brings invaluable industry experience and a demonstrated passion for developing and delivering value-added solutions for customers. I am confident that his appointment will enable VWR to build on its successful track record in EMEA-APAC and will help drive continued growth for the business." Dr. Clausnitzer, originally trained as a medical doctor, joins VWR from Qiagen N.V., where he served as President, Head of Commercial Operations EMEA. Prior to that, he held numerous leadership positions for major companies such as Abbott GmbH & Co. KG, Olympus GmbH, and Philips Electronics N.V. In his prior roles, Dr. Clausnitzer has gained experience across a number of functional areas, including Sales, Marketing, Operations, Service and Business Development. He additionally earned an MBA from the Open University in Milton Keynes, UK. About VWR VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is a leading, global, independent provider of products, services and solutions to laboratory and production facilities. With sales in excess of $4.3 billion in 2014, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers' productivity from research to production. VWR's differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 8,500 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals. For more information on VWR please visit www.vwr.com. Media Contact:Valerie ColladoDirector, Corporate CommunicationsVWR 484.885.9338Valerie_collado@vwr.com Investor Contact:John Sweeney, CFAVP, Investor RelationsVWR CorporationPhone: +610.386.1483ir@vwr.com Logo - http://photos.prnewswire.com/prnh/20101109/NY97837LOGO